[Survival analysis in people diagnosed with HIV/AIDS in Puerto Rico].

Revista Puertorriquena de medicina y salud publica Pub Date : 2018-01-01

Melissa Marzán-Rodríguez, Diego E Zavala Segarra, Juan Carlas Orengo Valverde, Nelson Varas-Díaz, Sandra Miranda De León, Eliseo Acevedo-Díaz

{"title":"[Survival analysis in people diagnosed with HIV/AIDS in Puerto Rico].","authors":"Melissa Marzán-Rodríguez, Diego E Zavala Segarra, Juan Carlas Orengo Valverde, Nelson Varas-Díaz, Sandra Miranda De León, Eliseo Acevedo-Díaz","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>After the introduction of HAART, the HIV/AIDS epidemiological trends has shown an increasing in the survival rates. HAART has dramatically improved the life expectancy of HIV/AIDS. The objective of this study was to estimate survival in people diagnosed with HIV/AIDS in Puerto Rico (PR) from 2003-2011. A population-based study using the PR HIV Surveillance System was implemented. A total of N = 9,290 people were diagnosed with HIV/AIDS in PR for 2003-2011 period. Cox regression models for survival analysis were assessed. Survival at 6 years after diagnosis in HIV patients was 0.87 (CI95%: 0.09, 0.72) when compare with AIDS patients at same time of diagnosis was 0.57 (CI95%: 0.55, 0.60) p<0.001. Intravenous drug users [IDU] have less probability of survival at 5 years after diagnosis when compare with other transmission modes 0.69 (CI95%: 0.67, 0.71) p<0.001. Assertive prevention strategies must be developed and implemented in PR for IDU's in order to increase their survival rates.</p>","PeriodicalId":92441,"journal":{"name":"Revista Puertorriquena de medicina y salud publica","volume":"66 ","pages":"8-14"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097805/pdf/nihms976325.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Puertorriquena de medicina y salud publica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

After the introduction of HAART, the HIV/AIDS epidemiological trends has shown an increasing in the survival rates. HAART has dramatically improved the life expectancy of HIV/AIDS. The objective of this study was to estimate survival in people diagnosed with HIV/AIDS in Puerto Rico (PR) from 2003-2011. A population-based study using the PR HIV Surveillance System was implemented. A total of N = 9,290 people were diagnosed with HIV/AIDS in PR for 2003-2011 period. Cox regression models for survival analysis were assessed. Survival at 6 years after diagnosis in HIV patients was 0.87 (CI95%: 0.09, 0.72) when compare with AIDS patients at same time of diagnosis was 0.57 (CI95%: 0.55, 0.60) p<0.001. Intravenous drug users [IDU] have less probability of survival at 5 years after diagnosis when compare with other transmission modes 0.69 (CI95%: 0.67, 0.71) p<0.001. Assertive prevention strategies must be developed and implemented in PR for IDU's in order to increase their survival rates.

Abstract Image

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[波多黎各HIV/AIDS患者的生存分析]。

在采用高效抗逆转录病毒疗法后，艾滋病毒/艾滋病流行病学趋势显示存活率有所上升。HAART极大地提高了艾滋病毒/艾滋病患者的预期寿命。本研究的目的是估计2003-2011年波多黎各(PR)被诊断患有艾滋病毒/艾滋病的人的生存率。使用PR艾滋病毒监测系统实施了一项基于人群的研究。2003-2011年期间，共有9290人被诊断患有艾滋病毒/艾滋病。对生存分析的Cox回归模型进行评估。HIV患者确诊后6年生存率为0.87 (CI95%: 0.09, 0.72)，而同期艾滋病患者的生存率为0.57 (CI95%: 0.55, 0.60) p

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助